THE HARPLE GROUP, LLC

Lobbying for ELI LILLY & COMPANY · Biopharmaceutical company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Indiana · $10,000.00 income · posted Apr 14, 2026

Lobbying activity 1

Health Issues

Monitored Issues and advised clients on matters related to Pharmaceutical supply chain security and resiliency.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.